Prothena Corporation plc Live Stock Price Today, Share Analysis and Chart

Name: Prothena Corporation plc: Is Infosys Ltd. worth buying?
Item: Prothena Corporation plc
Rating: 0.952611125
Author: Trendlyne DVM scores

Weak Stock

about

Prothena Corp PLC is a late-stage clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amy...

8.66 0.19 (2.24%)

26.61% Fall from 52W High

397.2K

XNAS Volume

XNAS 17 Jul, 2026 5:30 PM (EDT)

Low Financial Strength

11.1 / 100

Expensive Valuation

20.2 / 100

Technically Bearish

33.8 / 100

Weak Stock These stocks have poor scores across the board. Investors should be very cautious with these stocks View Similar Embed DVM

1Yr Price target upside is 147%

5 analysts

Prothena Corporation plc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Prothena Corporation plc Live Stock Price Today, Share Analysis and Chart

Prothena Corp PLC is a late-stage clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amy...

26.61% Fall from 52W High

SWOT Analysis

Prothena Corporation plc Live Price Chart

Prothena Corporation plc Live Price Chart